FRANKLIN RESOURCES INC - CELLDEX THERAPEUTICS INC NEW ownership

CELLDEX THERAPEUTICS INC NEW's ticker is CLDX and the CUSIP is 15117B202. A total of 150 filers reported holding CELLDEX THERAPEUTICS INC NEW in Q2 2023. The put-call ratio across all filers is 1.13 and the average weighting 0.3%.

Quarter-by-quarter ownership
FRANKLIN RESOURCES INC ownership history of CELLDEX THERAPEUTICS INC NEW
ValueSharesWeighting
Q2 2023$780,492
+280.7%
23,003
+333.9%
0.00%
Q4 2021$205,000
-26.5%
5,301
+2.5%
0.00%
Q3 2021$279,0005,1720.00%
Other shareholders

There were no reported owners of CELLDEX THERAPEUTICS INC NEW in Q2 2023.

NameSharesValueWeighting ↓
View complete list of CELLDEX THERAPEUTICS INC NEW shareholders